NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT — Class II drug recall D-231-2013
Terminated recall by Palmer Natural Products, reported 2013-04-10, distributed in CA, FL, ID. Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
| Recall number | D-231-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Palmer Natural Products, Star, ID, United States |
| Recall initiated | 2013-03-11 |
| Classified | 2013-04-01 |
| Reported by FDA | 2013-04-10 |
| Terminated | 2013-08-07 |
| Distributed | CA, FL, ID |
| Countries outside the US | HK |
| Quantity | 672 bottles |
| Reason classes | unapproved product |
Product
NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.COM. DEVELOPED BY: Digital Superfuture Limited Arntel Building 9B 148 Des Voeux Rd. Hong Kong.
Reason for recall
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-231-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.